You are reading the report for 2026-09-28. The figures are as they stood that day and are not revised. See the current report →

Daily Special Report

Published Sep 29

The Street Split Watch List

Where the analysts disagree

4 companiesData through Sep 28

The widest disagreement runs from +4% for PEP to +179% for MSTR. Those figures compare each most recent target with the price at the time it was set, so they are not readings against one shared price. Grade changes and price targets were published in the latest analyst feed; analyst opinion is not a recommendation.

Gap between the latest price target and the current priceTARGET VS CURRENT PRICE · PUBLISHED RANGEPEP+4%MIRM+124% $144 – $195MRVL+30% $330 – $360MSTR+179%

Entry by entry — why each one is on the board

PEPPepsiCo, Inc.
Split3 up / 2 down
Target vs price+4%
Range—

PEP is the only company here with 3 up / 2 down among analyst views. Its +4% gap between target and price is the smallest of the 4 here.

split: 3 up, 2 down · Cowen & Co., Deutsche Bank, Jefferies

MIRMMirum Pharmaceuticals, Inc.
Split—
Target vs price+124%
Range$144 – $195

Against a target range of $144 – $195, MIRM has no up/down count shown. Its +124% gap between target and price is the second-largest of the 4 here.

targets $144-$195 · H.C. Wainwright, Morgan Stanley

MRVLMarvell Technology, Inc.
Split—
Target vs price+30%
Range$330 – $360

By contrast, MRVL has no up/down count shown, with targets ranging from $330 – $360. The +30% gap between its target and price is the third-largest of the 4 here.

targets $330-$360 · Cantor Fitzgerald, RBC Capital

MSTRStrategy Inc
Split—
Target vs price+179%
Range—

At the widest end, MSTR has no up/down count shown and a +179% gap between target and price. That is the biggest gap between target and price of the 4 here, while its band (—) is shared with PEP.

Coker Palmer

How this board was built

Grade changes and price targets published in the latest analyst feed. “Target vs price” compares the most recent target with the price at the time it was set. Analyst opinion is not a recommendation.